Thompson KM - Search Results

1

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination.

Thompson KM. Thompson KM. Vaccines (Basel). 2024 Oct 25;12(11):1210. doi: 10.3390/vaccines12111210. Vaccines (Basel). 2024. PMID: 39591113 Free PMC article.

2

Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036.

Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Expert Rev Vaccines. 2022 Nov;21(11):1667-1674. doi: 10.1080/14760584.2022.2128108. Epub 2022 Oct 5. Expert Rev Vaccines. 2022. PMID: 36154436 Free PMC article.

3

Health economic analyses of secondary vaccine effects: a systematic review and policy insights.

Thompson KM, Badizadegan K. Thompson KM, et al. Expert Rev Vaccines. 2022 Mar;21(3):297-312. doi: 10.1080/14760584.2022.2017287. Epub 2022 Jan 12. Expert Rev Vaccines. 2022. PMID: 34927511 Free article.

4

Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).

Thompson KM, Badizadegan K. Thompson KM, et al. Expert Rev Vaccines. 2024 Jan-Dec;23(1):597-613. doi: 10.1080/14760584.2024.2361060. Epub 2024 Jun 7. Expert Rev Vaccines. 2024. PMID: 38813792 Free article. Review.

5

Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.

Thompson KM, Kalkowska DA. Thompson KM, et al. Expert Rev Vaccines. 2020 Jul;19(7):661-686. doi: 10.1080/14760584.2020.1791093. Epub 2020 Aug 1. Expert Rev Vaccines. 2020. PMID: 32741232 Free PMC article. Review.

6

Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication.

Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Expert Rev Vaccines. 2021 Apr;20(4):449-460. doi: 10.1080/14760584.2021.1891889. Epub 2021 May 5. Expert Rev Vaccines. 2021. PMID: 33599178 Free article. Review.

7

Oral polio vaccine stockpile modeling: insights from recent experience.

Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):813-825. doi: 10.1080/14760584.2023.2263096. Epub 2023 Sep 29. Expert Rev Vaccines. 2023. PMID: 37747090 Free article. Review.

8

Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.

Thompson KM, Odahowski CL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1297-314. doi: 10.1111/risa.12331. Epub 2014 Dec 24. Risk Anal. 2016. PMID: 25545778 Review.

9

Systematic Review of Measles and Rubella Serology Studies.

Thompson KM, Odahowski CL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1459-86. doi: 10.1111/risa.12430. Epub 2015 Jun 16. Risk Anal. 2016. PMID: 26077609 Review.

10

The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies.

Thompson KM, Odahowski CL. Thompson KM, et al. Risk Anal. 2016 Jul;36(7):1357-82. doi: 10.1111/risa.12459. Epub 2015 Aug 5. Risk Anal. 2016. PMID: 26249331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters